Shield Therapeutics

STX · AIM · Health Care · mcap £63m · 5.3p

Beta Briefing, track record and bull & bear case are not ready for Shield Therapeutics yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 51 companies are already wired into a briefing: browse them.

Directors

No open-market share purchases by directors in 12 months.

Company filings. Not investment advice.